The US Food and Drug Administration (FDA) has approved a product known as enzalutamide (Xtandi®) to be used in a new way. The body, after an in-depth review says that it is ideal for handling a condition called prostate cancer (mHSPC). A close outlook Sometime back, the company gave its approval to the product for […]
Sign Up To Get Our Instant Alerts!
- Tesla Suspends Hiring Further Set to Lay Off 10% of its Labor Force 37 views
- Tata Motors Eyeing to Acquire Ford’s Factory in India 36 views
- Tesla Increases Vehicle Prices Once Again 36 views
- Futuris Company Expands With Historic Building Purchase 35 views
- Sequoia Capital Raises $2.85 Billion to Fund Indian and Southeast Asian Startups 35 views